ARCHIVES

NIDA Supports Phase III Trial of Anti-Tobacco Vaccine

This article is from The Cancer Letter archive.

Vol. 35 No. 41 | November 6, 2009

Download PDF Visit The Full Archive

Related Articles

FDA Approives Lilly’s Alimta For 1st-Line Metastatic NSCLC

September 26, 2008

In Brief: Chemical Carcinogenesis, Epidemiology Trail Viral Oncology In Budget Growth, Board Notes

November 7, 1980

American Legacy Foundation Says Group is Fighting For Its Survival.

January 7, 2005

National Standards For Science Education Issued By Committee Led By NCI Director

December 15, 1995

MD Anderson President Ronald DePinho: “Some of the Feedback was Humbling”

March 29, 2013

In Brief: Pediatric Groups Endorse Merger Plan; NCI Charters Consumer Liaison Group

November 13, 1998